TABLE 2.

Outcomes Among Children Hospitalized With CAP According to Empiric Antimicrobial Therapy (N = 15 564)

	Ceftriaxone/Cefotaxime (n = 13 954)	Penicillin/Ampicillin (n = 1,610)	Adjusted MD or OR (95% CI)
LOS, d	3 [3–4]	3 [3–4]	MD 0.12 (–0.02 to 0.26)
Cost ($), index hospitalization	3992 [2895–5713]	4375 [3390–5805]	MD –14.4 (–177.1 to 148.3)
Cost ($), episode of illness	4036 [2919–5857]	4407 [3405–5913]	MD –18.6 (–194 to 156.9)
ICU admission	156 (1.1)	13 (0.8)	OR 0.85 (0.27 to 2.73)
14-day readmission	321 (2.3)	39 (2.4)	OR 0.85 (0.45 to 1.63)

Data presented as median [IQR] or n (%). Models adjusted for age, gender, race/ethnicity, payer, asthma comorbidity, previous hospitalization, month and year, resource utilization (oxygen therapy, blood products, chest ultrasound and computed tomography, blood gas analysis), and concomitant medication use (macrolides, bronchodilators, corticosteroids, oseltamivir). CI, confidence interval; MD, mean difference; OR, odds ratio.